CHINA SCIO

 ㄑ Press Room ㄑ Press Conference Transcripts ㄑ Press Conferences of the State Council Information Office

SCIO briefing on China's import and export performance in H1 2021

Economy
On July 13, the State Council Information Office (SCIO) held a press conference in Beijing to brief the media about China's import and export performance in the first half of 2021.

China.org.cnUpdated:  July 16, 2021

Jiemian:

Just now you talked about the export of private enterprises and cross-border e-commerce businesses. I would like to ask what portion was taken by private enterprises in the cross-border e-commerce sector? I would also like to know the growth rate of CNY-denominated export in June alone. Also how does the GACC view the change in the new export order index in May and June? Thank you.

Li Kuiwen:

Thank you for your questions. We have just provided the latest purchasing managers' index (PMI) statistics. As shown by the latest economic data we have been following, the economy is now strengthening and improving steadily. As for the fluctuations, we have been monitoring them and analyzing their impact on foreign trade. 

Regarding the latest data on cross-border e-commerce, I have just now given the H1 data. Thank you.

Phoenix TV:

I would like to ask about China's export of COVID-19 vaccines. What measures have the customs departments taken to ensure their speedy clearance? Thank you.

Li Kuiwen:

Thank you for your question. China has always adhered to the vision of a global community of health for all and actively participated in COVAX (COVID-19 Vaccines Global Access). In the face of massive domestic demand and a tight supply, we have done our best to provide vaccines to other countries, contributing to global equitable distribution and use of vaccines and global cooperation against the pandemic and winning praises from the international community.

The GACC has rolled out an array of measures to ensure the speedy clearance of COVID-19 vaccines this year. We actively contacted COVID-19 vaccine export enterprises to explain export procedures and provide full-chain guidance. We also sped up clearance of urgently-needed major production equipment to help expand vaccine production capacity. Meanwhile, we contacted export enterprises to help them address practical difficulties and needs in a timely manner. We built a whole-process tracking platform as part of our efforts to shorten the clearance time. Currently, the time for health and quarantine approval has been shortened from 20 working days to two hours for exported vaccines, and the clearance time has been reduced to less than three hours. While ensuring the safe and speedy clearance of vaccines, the GACC has also taken multiple measures to crack down on illegal exit of COVID-19 vaccines. According to statistics, in the first half of this year, China provided over 500 million doses of COVID-19 vaccines and concentrates to 121 countries and international organizations, accounting for one-sixth of the current global COVID-19 vaccine production and making important contributions to international cooperation against COVID-19 and economic recovery. Thank you.

Shou Xiaoli:

Today's press conference is hereby concluded. Thank you, Mr. Li and friends from the media. See you next time.

Translated and edited by Wang Yiming, Wang Qian, Lin Liyao, Li Huiru, Duan Yaying, Wang Zhiyong, Zhang Tingting, Wang Wei, Cui Can, Huang Shan, Zhang Rui, Chen Xia, Qin Qi, Yuan Fang, Jay Birbeck, and Tom Arnstein. In case of any discrepancy between the English and Chinese texts, the Chinese version is deemed to prevail.

<  1  2  3  4  5  6  7  8  9  10  


MORE FROM China SCIO